Tracy Kemp

Tracy has 25 years of experience in global drug development and clinical operations from preclinical research through Phase I-IV trials and regulatory submissions. Most recently with BioProtection Systems, the infectious disease subsidiary of NewLink Genetics, Tracy was responsible for the oversight of all clinical contract activities supporting the development of the rVSV-ZEBOV Ebola vaccine, in partnership with Merck & Co.

Prior to her work on rVSV-ZEBOV Ebola, Tracy was the clinical lead at Acambis Inc., where she was responsible for the oversight of clinical operations for various vaccine programs, including Japanese encephalitis, West Nile, Helicobacter pylori, Clostridium difficile, and the ACAM2000® smallpox vaccine.

Tracy has significant experience in clinical contract and budget management, program feasibility, identification and management of relationships with Key Opinion Leaders and strategic partners, as well as internal/external team management. Tracy has a strong background and industry experience in various indications, including rare diseases, oncology, CNS, and infectious disease, working for Millennium (Takeda Oncology), Synageva BioPharma, Shire, Biogen, and Cubist.

Prior to her work in the industry, Tracy was fortunate to serve as a Peace Corps Volunteer in Nigeria, supporting local health information collection initiatives for the Federal Ministry of Health and working on retrospective case studies of oral rehydration techniques for malaria.

Tracy did her undergraduate work at Rollins College and has a Master’s Degree in Public Health from Boston University with a focus in Epidemiology.